FDA Inspection 1181017 — Imperial Drug And Spice Company
The FDA completed an inspection of Imperial Drug And Spice Company on Sep 13, 2022 in West New York, NJ. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Food/Cosmetics.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Sep 13, 2022
- Fiscal Year
- 2022
- Product Type
- Food/Cosmetics
- Project Area
- Colors and Cosmetics Technology
- Location
- West New York, NJ (United States)